Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) Non Operating Income (2016 - 2017)

Collegium Pharmaceutical has reported Non Operating Income over the past 2 years, most recently at $180000.0 for Q4 2017.

  • Quarterly results put Non Operating Income at $180000.0 for Q4 2017, up 800.0% from a year ago — trailing twelve months through Dec 2017 was $582000.0 (up 719.15% YoY), and the annual figure for FY2017 was $582000.0, up 719.15%.
  • Non Operating Income for Q4 2017 was $180000.0 at Collegium Pharmaceutical, up from $167000.0 in the prior quarter.
  • Over the last five years, Non Operating Income for COLL hit a ceiling of $180000.0 in Q4 2017 and a floor of -$66000.0 in Q1 2016.